Open | $11.640 |
Close | $11.980 |
Volume / Avg. | 7.592K / 9.903K |
Day Range | 11.450 - 11.990 |
52 Wk Range | 5.000 - 25.600 |
Market Cap | $12.047M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 0.08% |
Days to Cover | 1.62 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Addex Therapeutics (NASDAQ: ADXN) through any online brokerage.
Other companies in Addex Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH), Evaxion Biotech (NASDAQ:EVAX) and Coeptis Therapeutics (NASDAQ:COEP).
The latest price target for Addex Therapeutics (NASDAQ: ADXN) was reported by HC Wainwright & Co. on Thursday, June 23, 2022. The analyst firm set a price target for 0.00 expecting ADXN to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Addex Therapeutics (NASDAQ: ADXN) is $11.37 last updated March 18, 2024 at 9:25 AM EDT.
There are no upcoming dividends for Addex Therapeutics.
Addex Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Addex Therapeutics.
Addex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.